Glenmark Pharmaceuticals Q3 Results 2025:Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ...

Deere faced a challenging quarter as earnings and revenue significantly declined year over year amidst unfavorable market ...

Canadian Tire Corporation, Limited (CTC or the Company) today announced results for its fourth quarter and full year ended . Strong December sales drove a return to comparable sales growth in ...

Canadian Tire has been executing its Better Connected strategy, modernizing core retail foundational elements by investing in ...

CFO Tina Miller reported $419 million in adjusted EBITDA for the quarter, accompanied by free cash flows of $180 million. She noted that financing operations achieved profitability of $9 million in ...

(NYSE: CXW) has reported its fourth quarter and full year 2024 financial results, highlighting a strong financial performance ...

Higher Occupancy and Cost Management Drive Strong Financial PerformanceEstablishes 2025 Full Year Guidance BRENTWOOD, Tenn., Feb. 10, 2025 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) (CoreCivic or ...

The 27 analysts following T-Mobile US have set target prices ranging from $184.95 to $290.0 per share, for an average of $253 ...

Higher Occupancy and Cost Management Drive Strong Financial PerformanceEstablishes 2025 Full Year GuidanceBRENTWOOD, Tenn., Feb. 10, 2025 ...